PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Phillips DiPisa

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Phillips DiPisa’s Kevin Carroll Co-Authors Article in The Monitor - Kevin Carroll, a Phillips DiPisa associate, co-authors an article that appears in a leading pharmaceutical trade publication, The Monitor, in its September, 2007 issue. The article is entitled, “An Executive Recruiter’s Perspective on Hiring for CRP
Phillips DiPisa’s Kevin Carroll Co-Authors Article in The Monitor

 

NewswireToday - /newswire/ - Hingham, MA, United States, 2007/09/29 - Kevin Carroll, a Phillips DiPisa associate, co-authors an article that appears in a leading pharmaceutical trade publication, The Monitor, in its September, 2007 issue. The article is entitled, “An Executive Recruiter’s Perspective on Hiring for CRP.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Phillips DiPisa, an executive search firm serving life sciences, healthcare providers and managed care organizations, today announced that one of its associates, Kevin Carroll, has co-authored an article. The Monitor, a leading pharmaceutical trade publication, published this piece in its September, 2007 issue. The article is entitled, “An Executive Recruiter’s Perspective on Hiring for CRP, Pharmaceutical, and Biotechnology Companies.”

The article offers perspectives on how executive recruiting and search firms need to adapt to meet the challenges of the ever-evolving pharmaceutical industry. It considers the trends and changing practices that affect executive search firms and their clients in the drug development arena.

Kevin Carroll leads the life sciences practice at Phillips DiPisa. He has thirteen years of executive recruiting and sales experience in the pharmaceutical, biotechnology and medical device industries. He focuses on searches for senior executives for commercial, medical and clinical research roles.

Kevin Carroll co-authored this article with Jeff Souza, who leads the commercial staffing business in North and South America for i3 Pharma Resourcing.

About Phillips DiPisa

Phillips DiPisa (phillipsdipisa.com) recruits leaders for healthcare providers, managed care organizations and life sciences firms. The firm’s roots are in Greater Boston – a historical center of medical innovation and excellence. Phillips DiPisa now serves clients along the East Coast and throughout the Midwest, and draws on a national pool of candidates.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Phillips DiPisa

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Phillips DiPisa’s Kevin Carroll Co-Authors Article in The Monitor

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Beth Mills - PhillipsDiPisa.com 
781-740-9699 bamills[.]phillipsdipisa.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Phillips DiPisa securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Phillips DiPisa / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)